Miromatrix CEO Jeff Ross Delivering Keynote Address at ARMI | BioFabUSA 2022 Fall Summit: Meeting in the Millyard

Rhea-AI Summary

Miromatrix Medical Inc. (NASDAQ: MIRO) announced CEO Jeff Ross will deliver a keynote address at BioFabUSA’s 2022 Fall Summit on October 26, 2022. This event, hosted by the Advanced Regenerative Manufacturing Institute (ARMI), aims to unite leaders in biofabrication to discuss advancements in cell, tissue, and organ therapies. Miromatrix focuses on bioengineering fully transplantable organs, primarily developing human livers and kidneys through its proprietary perfusion technology platform.

Positive

• CEO Jeff Ross is a keynote speaker at a prominent industry event, enhancing company visibility.
• The focus on bioengineering transplantable organs addresses critical shortages in human organs.

Negative

• None.

EDEN PRAIRIE, Minn., Oct. 19, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients' lives, today announced that CEO Jeff Ross will be a keynote speaker at BioFabUSA’s 2022 Fall Summit from the Advanced Regenerative Manufacturing Institute (ARMI).

Mr. Ross will be a keynote speaker at ARMI|BioFab’s 2022 Fall Summit: The Meeting in the Millyard on October 26^th, 2022. The summit brings together biofabrication executives and top-decision industry makers developing life-saving cell, tissue, and organ therapies and the enabling technologies to manufacture and deliver these products at scale. Key focus areas will include objectives to create this cell, tissue and organ manufacturing industry and supporting ecosystem. Registration for the conference is available here.

About Miromatrix
Miromatrix Medical Inc. is a life sciences company pioneering a novel technology for bioengineering fully transplantable human organs to help save and improve patients' lives. The Company has developed a proprietary perfusion technology platform for bioengineering organs that it believes will efficiently scale to address the shortage of available human organs. The Company's initial development focus is on human livers and kidneys. For more information, visit miromatrix.com.

Investor Contact
Greg Chodaczek
347-620-7010
ir@miromatrix.com

Media Contact:
press@miromatrix.com

 

FAQ

What is Miromatrix Medical's stock symbol?

Miromatrix Medical Inc.'s stock symbol is MIRO.

When will the BioFabUSA 2022 Fall Summit occur?

The BioFabUSA 2022 Fall Summit will take place on October 26, 2022.

Who is the keynote speaker at the BioFabUSA 2022 Fall Summit?

CEO Jeff Ross of Miromatrix Medical will be the keynote speaker.

What topics will be discussed at the BioFabUSA summit?

The summit will cover advancements in biofabrication, organ therapies, and cell and tissue manufacturing.

What technology does Miromatrix specialize in?

Miromatrix specializes in bioengineering fully transplantable human organs using proprietary perfusion technology.